CLIN CANCER RES 2019 10.1158/1078-0432.CCR-19-1324
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
Willis1, J; Lefterova, MI; Artyomenko, A; Kasi, PM; Nakamura, Y; Mody, K; Catenacci, DVT; Fakih, M; Barbacioru, C; Zhao, J; Sikora, M; Fairclough, SR; Lee, H; Kim, KM; Kim, ST; Kim, J; Gavino, D; Benavides, M; Peled, N; Nguyen, T; Cusnir, M; Eskander, RN; Azzi, G; Yoshino, T; Banks, KC; Raymond, VM; Lanman, RB; Chudova, DI; Talasaz, A; Kopetz, S; Lee, J; Odegaard, JI

TRANSL ONCOL 2019 10.1016/j.tranon.2019.07.017
Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study
Kwon1, D; Kim, B; Shin, HC; Kim, EJ; Ha, SY; Jang, KT; Kim, ST; Lee, J; Kang, WK; Park, JO; Kim, KM

INT J CANCER 2019 10.1002/ijc.32228
Bridging genomics and phenomics of gastric carcinoma
Cho1, J; Ahn, S; Son, DS; Kim, NKD; Lee, KW; Kim, S; Lee, J; Park, SH; Park, JO; Kang, WK; An, JY; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Kim, KM

J IMMUNOTHER 2019 10.1097/CJI.0000000000000283
LAG3 in Solid Tumors as a Potential Novel Immunotherapy Target
Lee1, SJ; Byeon, SJ; Lee, J; Park, SH; Park, JO; Park, YS; Kang, WK; Lim, HY; Kim, KM; Kim, ST

CANCER DISCOV 2019 10.1158/2159-8290.CD-19-0442
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial
Lee1, J; Kim, ST; Kim, K; Lee, H; Kozarewa, I; Mortimer, PGS; Odegaard, JI; Harrington, EA; Lee, J; Lee, T; Oh, SY; Kang, JH; Kim, JH; Kim, Y; Ji, JH; Kim, YS; Lee, KE; Kim, J; Sohn, TS; An, JY; Choi, MG; Lee, JH; Bae, JM; Kim, S; Kim, JJ; Min, YW; Min, BH; Kim, NKD; Luke, S; Kim, YH; Hong, JY; Park, SH; Park, JO; Park, YS; Lim, HY; Talasaz, A; Hollingsworth, SJ; Kim, KM; Kang, WK

CANCER RES TREAT 2019 10.4143/crt.2019.019
Inter-observer Reproducibility in the Pathologic Diagnosis of Gastric Intraepithelial Neoplasia and Early Carcinoma in Endoscopic Submucosal Dissection Specimens: A Multi-center Study
Kim1, OM; Sohn, JH; Cho, MY; Kim, WH; Chang, HK; Jung, ES; Kook, MC; Jin, SY; Chae, YS; Park, YS; Kang, MS; Kim, H; Lee, JH; Park, D; Kim, KM; Kim, H; Suh, YJ; Seol, SY; Jung, HY; Kim, DH; Lee, NR; Park, SH; You, JH

PATHOL RES PRACT 2019 10.1016/j.prp.2019.152525
Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum
Kwon1, MJ; Byeon, S; Kang, SY; Kim, KM

PATHOL RES PRACT 2019 10.1016/j.prp.2019.152434
CCNE1 amplification is associated with liver metastasis in gastric carcinoma
Kim1, B; Shin, HC; Heo, YJ; Ha, SY; Jang, KT; Kim, ST; Kang, WK; Lee, J; Kim, KM

PATHOLOGY 2019 10.1016/j.pathol.2019.01.013
Gastrointestinal stromal tumour with CDKN2A deletions: a report of three cases
Kim1, B; Ha, SY; Lee, S; Kim, KM

J MOL DIAGN 2019 10.1016/j.jmoldx.2019.02.007
Tumor Heterogeneity Index to Detect Human Epidermal Growth Factor Receptor 2 Amplification by Next-Generation Sequencing A Direct Comparison Study with Immunohistochemistry
Choi1, S; Chu, J; Kim, B; Ha, SY; Kim, ST; Lee, J; Kang, WK; Han, H; Sohn, I; Kim, KM

SCI REP-UK 2019 10.1038/s41598-019-46216-6
Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue
Heo1, YJ; Park, C; DoyeongYu; Lee, J; Kim, KM

Am J Transl Res 2019
Neutralizing antibody to FGFR2 can act as a selective biomarker and potential therapeutic agent for gastric cancer with FGFR2 amplification
Kim1, ST; Lee, IK; Rom, E; Sirkis, R; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, KM; Yayon, A; Lee, J

J Cancer 2019 10.7150/jca.30257
High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer
Kim1, Y; Byeon, SJ; Hur, J; Lee, K; Kim, D; Ahn, JH; Lee, SH; You, WK; Kim, ST; Park, SH; Kang, WK; Kim, KM; Lee, J

J GASTROEN HEPATOL 2019 10.1111/jgh.14756
Outcomes of endoscopic submucosal dissection for intestinal-type adenocarcinoma with anastomosing glands of the stomach
Kim1, TS; Kim, B; Min, BN; Min, YW; Lee, H; Lee, JH; Rhee, PL; Kim, JJ; Kushima, R; Kim, KM

ONCOLOGY-BASEL 2019 10.1159/000499628
Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial
Miceli1, R; An, J; Di Bartolomeo, M; Morano, F; Kim, ST; Park, SH; Choi, MG; Lee, JH; Raimondi, A; Fuca, G; Sohn, TS; Bae, JM; Kim, S; Lim, DH; Kang, WK; Kim, KM; Pietrantonio, F; Lee, J

Front Oncol 2019 10.3389/fonc.2019.00212
Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort
Lee1, J; Franovic, A; Shiotsu, Y; Kim, ST; Kim, KM; Banks, KC; Raymond, VM; Lanman, RB

SURGERY 2019 10.1016/j.surg.2018.11.001
Effect of age on the clinical outcomes of patients with early gastric cancer with undifferentiated-type histology
Pyo1, JH; Lee, H; Min, YW; Min, BH; Lee, JH; Kim, KM; Yoo, H; Kim, K; Choi, YH; Kim, JJ; Kim, S

TRANSL ONCOL 2019 10.1016/j.tranon.2018.12.009
Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I Trial
Kim1, ST; Lee, S; Park, M; Park, SH; Park, JO; Lim, HY; Park, YS; Kang, WK; Gangolli, EA; Shin, H; Kim, KM; Hollingsworth, SJ; Mortimer, PGS; Lee, J

ANN ONCOL 2019 10.1093/annonc/mdy550
Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer
Sundar1, R; Huang, KK; Qamra, A; Kim, KM; Kim, ST; Kang, WK; Tan, ALK; Lee, J; Tan, P

PATHOL RES PRACT 2019 10.1016/j.prp.2018.11.010
MET is overexpressed in microsatellite instability-high gastric carcinoma
Sim1, J; Heo, YJ; Bae, H; Shin, HC; Kim, B; Cho, J; Kim, ST; Lee, J; Kang, WK; Kim, KM